Follow the RaySearch Laboratories AB (publ) stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, RaySearch Laboratories AB (publ) has logged 22 insider filings. Market capitalisation: €6.6bn. The latest transaction was reported on 18 August 2026 (Sale). Among the most active insiders: Kjell Eriksson. The full history is free.
22
Insider Decl.
n/a
Thresholds
€799,103
16 ops.
Buy Volume
€46m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate RaySearch Laboratories AB (publ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 297.50.
43Σ signal
Buys €799,103€46m Sells
Fundamental score
Ranked 3,388 of 28,958 companies
72.2
score / 100
Value
59
Quality
86
FCF yld3.0%
Earn yld4.2%
EV/EBITDA9.8x
ROE26%
Gross mgn92%
Net mgn17%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,000,000 shares@ €22.6690.72% mcap100.0% of flowAktieISINISIN SE0000135485FI:A003M758-1
22 of 22 declarations
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ) is a Swedish company that develops software for radiation therapy. It is listed on the Stockholm Stock Exchange (XSTO).